This event will forecast potential health policy priorities for both states and the federal government and review major milestones from the past year and their potential impact on 2023.
The final event in the 2022 Signature Series will outline how federal funding is allocated, distributed, and ultimately used by states and community organizations.
This briefing defined the differences between SDOH, social drivers of health, social needs, and social risk factors and outlined potential policy solutions at the federal, state, and local levels.
Panelists discussed upcoming priorities for the lame-duck session of the 117th Congress, implications for the 118th Congress, and priorities for the Biden Administration.
This event discussed past and current trends in market consolidation ecosystem, explored current legislative and administrative policy levers, and identified lessons learned at the state and federal levels.
This event explored lessons for public health from the HIV/AIDS experience and how they mapped to COVID-19 and monkeypox response efforts.
This event reviewed the importance and use of health data in addressing health disparities, the main barriers that persist in limitations to health data, and policy levers that can improve health data collection and utilization at the federal level.
This briefing discussed what a successful and effective public health system looks like, illustrated how the U.S. can better meet every day public health challenges, and explored how an efficient and effective public health system can more effectively anticipate and respond to public health emergencies.
The Summit on Mental Health in America will feature industry visionaries, administration executives, and a host of experts to discuss topic areas such as equitable inclusion, innovation, and workforce capacities.
This event outlined the various coverage-related elements at play over the next six to nine months, their tradeoffs, and how they may impact various stakeholders, including consumers, state leaders, and payers.
During this session, panelists provided an overview of the role of the FDA particularly focusing on the approval process required to bring new medical products to market.
During this exclusive briefing, former CMS Administrators Nancy Ann-DeParle and Dr. Mark McClellan provided a forward-thinking perspective about the implications of policy changes to the Medicare program.
During this session, panelists provided an overview of home and community-based services, including populations receiving these services, current enrollment numbers, workforce challenges, benefits of HCBS, and barriers to caring for complex populations.
This session helped attendees consider the implications of policy options to promote Medicare sustainability. Panelists explored trends in Medicare spending; introduced key concepts related to Medicare financing and solvency; and explored the implications of policy options to promote Medicare sustainability.
This session provided insight into the Medicare population, enrollment trends, and affordability considerations for beneficiaries in traditional Medicare and Medicare Advantage.
During this session, panelists reviewed the basic mechanisms of the Medicare program, with specific focus on traditional Medicare (Parts A and B) and Medicare Advantage (Part C).
This event helped the audience understand the current policy landscape shaping Medicare and Medicaid programs as well as principles of person- and community-centered care. Speakers discussed lessons learned from the PHE, including insights from recent research and on-the-ground experts, and highlighted policy levers available to state and federal policymakers to build upon these current flexibilities.
This event explained user fee programs and their role within the drug development and FDA regulatory review process. Panelists provided insights on the stakeholders, timeline, the process of reauthorization, the history of these bills being used for broader health legislative initiatives, and explored lessons learned.
This briefing provided a round-up of state-level policies enacted during the past few years that are focused on cost containment, complex care, and drug pricing reform. Panelists overviewed health policies implemented and evaluated at the state level, synthesize major lessons and takeaways from these policies, and highlighted states or programs to watch in 2022.
This event highlighted current trends in enrollment, premiums, and out-of-pocket costs in private insurance markets, and presented challenges and opportunities in getting eligible consumers enrolled in appropriate coverage. Panelists also explored coverage affordability and enrollment levers, including potential policy actions at federal and state levels.
This event explored health policy milestones from the past year and their potential impact on 2022. Panelists offered a high-level analysis of the policies that Congress and the administration have pursued to date, potential implementation opportunities and challenges, as well as current health-related court cases.
In this briefing, experts overviewed demographics of the Native American population in the United States as well as the current policy and regulatory landscape that guides and directs Native American health care infrastructure.
In this briefing, experts overviewed what comprises the field of environmental health and its corresponding policy, outlined the major players at the state and federal level, and highlighted immediate policy opportunities. Panelists also discussed how health disparities and inequities are tied to environmental factors and offered thoughts on how to close policy gaps.
Voices from the Frontlines brought together leading voices in health care and public health for an afternoon of conversation and inspiration. For the first time, these exceptional individuals, who have been paramount in the effort to combat COVID-19 over the past 18 months, were together on one virtual stage. This event allowed our community the opportunity to directly engage with those on the frontlines of this pandemic, and to hear their personal stories of perseverance in the face of great challenge.
In this briefing, experts overviewed the specific health and access challenges faced by people experiencing homelessness. Panelists also offered insights on how to deliver effective health care to this population, with a specific focus on barriers to access and potential policy strategies to alleviate these barriers.
This 3-hour summit convened and informed health policy and oncology research communities about critical issues related to patient-centered cancer care and offered lessons, strategies, and policy approaches for the short and long term.
This briefing will examine the difference between perinatal health and perinatal mental health and their intrinsic relationship. Panelists will delve into factors contributing to perinatal health and mental health as well as policy levers and promising solutions available to stakeholders to reduce and prevent mental health symptoms and mood disorders.
This briefing provided a primer on health data, how we use it, and how we process it. Attendees learned the challenges of leveraging health data for decision-making and the implications for providers, payers, and patients during the COVID-19 pandemic.
This briefing will explore how the U.S. has fared during the COVID-19 pandemic to-date and highlight key takeaways learned in the U.S. response, as well as important lessons learned from peer countries.
In this briefing, experts discussed how flu and the COVID-19 pandemic have intersected over the past 18 months and why we should also prioritize flu preparedness policy. Panelists also highlighted available federal policy levers and discuss policy strategies to improve our flu response.
The Health Equity Summit, a program of the Alliance for Health Policy’s 2021 Signature Series, reflected upon lessons learned and look at policies and practices that perpetuate existing inequities in our society. Exploring a multitude of factors both current and historical, this Summit addressed the tradeoffs between inaction and intervention, as well as tangible policy options to start advancing health equity now.
This briefing provided background on Medicare payment reform, including new value-based models that have evolved over the past decade.
This briefing discussed the results of the latest African American Research Collaborative (AARC) survey regarding COVID-19 vaccines, their importance, and explored potential strategies to increase vaccination rates, particularly ones tailored to different populations.
This briefing examined the burgeoning mental health crisis, partially exacerbated by the COVID-19 pandemic, and will explore policy options to support increased mental health wellness at work and at home. This is the final event in Part I of the 2021 Signature Series focused on health and the economy.
This briefing will overview what rare diseases are and how we classify them, what populations rare diseases impact, and will focus on the challenges and potential solutions to better improve the diagnostic odyssey.
This briefing provided a brief landscape of the dual eligible population and the challenges they face when seeking comprehensive coverage and care. Attendees learned about the spectrum of integration of the Medicare and Medicaid programs on behalf of this population, and defined what success looks like in an integrated plan.
This event outlined the latest science on nicotine initiation, addiction, and cessation, the use of flavorings in tobacco products, as well as the disparate impact of menthol tobacco products on various populations, especially communities of color.
This briefing reviewed the opportunities and challenges that have arisen for first line providers and current integration efforts to ensure equitable preventative care for the American public. Experts addressed the role of data sharing, payment systems, and workforce provisions.
One day after the Supreme Court released their ruling, this briefing will help our audience understand what they are reading in the news and what to expect in the coming weeks and months from the courts, Congress, and the health care market.
This briefing will clarify the defining characteristics of Medicare Part D including eligibility, coverage, and benefits. Attendees will understand the case for Medicare Part D redesign and the implications and tradeoffs of current policy options on beneficiaries and other stakeholders.
The Health and the Economy Summit, a program of the 2021 Signature Series, explored how the health care ecosystem and the health of our nation’s population have become inextricably intertwined with the financial health of our country.
This session explored how cost-saving proposals like market competition and regulation address and impact a variety of factors and policies.
Expert panelists delved into where America stands in public health a year into the COVID-19 pandemic. They discussed how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
This briefing provided an overview of the Medicare Trust Funds, the nuances of solvency, and the consequences of not resolving funding shortfalls. Panelists explored short- and long-term policy options to address solvency and offer equitable access, as well as the potential impacts on providers, plans, and most importantly, Medicare beneficiaries.
This briefing provided a high-level overview of the budget reconciliation process and also discussed potential applications of reconciliation to address national economic and health policy concerns of the 117th Congress and the new administration.
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
This briefing explored the current state of COVID-19 vaccine deployment efforts, cultural, historical, and political influences that may generate feelings of hesitancy, and how to ensure optimal vaccine uptake in key populations.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This was the final event in Part II of our Signature Series focusing on the voice of the patient. This briefing explored the rise of consumer wearables as increasingly prevalent tools in health care delivery and as part of patient care plans.
This briefing provided an overview of how census data is collected, analyzed, and utilized, with a particular focus on how this process impacts health policy and public health.
Sessions on Day 2 of the Post Election Symposium included a fireside chat with futurist Ian Morrison and leaders from the ground discussed the long-term vision for rebuilding the health system.
Sessions on Day 1 of the Post Election Symposium provided an analysis of the election results and potential impacts for health care and a discussion on the gaps in our health care system that COVID-19 exposed.
November 16-17 | This virtual symposium will gather a range of experts after election day to discuss how the results could influence the health policy agenda in 2021 and beyond.
Two days after the oral arguments for Texas v. California, this panel will provide an overview of the arguments and questions posed while also addressing procedural next steps.
This briefing will overview the complex ecosystem of federal, state, and private programs that coexist to integrate medical, LTSS, and social services for low-income seniors.
Day 3 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will address how we collect and operationalize patient feedback to create patient-centered care at a systems level.
Day 2 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will explore successful mechanisms to support patients navigate the current, highly complex health care system and foster independence in decision making.
Day 1 of our Voice of the Patient Summit, a program of the 2020 Signature Series, includes an opening keynote presentation and panel focusing on strategies for effective communication and shared decision making from the patient and caregiver perspectives.
During this Summit, we will examine the patient’s voice across several levels of health care design, delivery, and measurement. This event is part of our ongoing 2020 Signature Series focusing on the Voice of the Patient.
The COVID-19 pandemic has exposed both new and longstanding needs of long-term care patients. Experts will overview the recent changes, remaining gaps, and benefits and risks to long-term care patients, caregivers, providers, and payers.
This is the final event in Part I of our Signature Series focusing on disruptors and transformers in health care. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake.
This solutions-focused discussion explored policy interventions at the federal, state, and local levels to advance mental health during the ongoing pandemic.
This webinar will address the specific threats posed by COVID-19 to children in the short- and long-term and provide policy options that may support children’s physical and mental health.
During this webinar, panelists will address key questions such as: How has the relief fund been distributed to date among different health care entities? What is the financial impact of the pandemic for providers and what are the implications for access to health services? And, what factors should policymakers consider as they weigh additional options to support providers?
Keynote: A Conversation on Innovative Research Approaches to Advance Our Understanding and Treatment of COVID-19
Keynote #2 of our Virtual Summit, a program of the 2020 Signature Series, will discuss the role of the National Institutes of Health’s National COVID Cohort Collaborative (N3C) program in fostering robust-data driven clinical research.
Panel #3 of our Virtual Summit, a program of the 2020 Signature Series, will explore the role of data sharing, interoperability, and health IT in tracking and stemming the spread of COVID-19.
Executive insights interview with Jenny Bryant of PhRMA.
Panel #2 of our Virtual Summit, a program of the 2020 Signature Series, will focus on care delivery and payment transformations that have been accelerated or emerged as a result of COVID-19 and explore which systemic changes may become permanent, as well as how to rebuild trust in the health care system.
Keynote #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore structural conditions that have lead to health disparities before COVID and during the current pandemic.
Panel #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore interactions between the vaccine development pipeline, medical supply chain, and contact tracing infrastructures currently serving the US, and how policymakers can leverage and improve these foundational systems moving forward.
Expert panelists will explore the short and long-term impacts of the COVID-19 crisis and its potential to significantly transform our health care system during our Virtual Summit, a program of our ongoing 2020 Signature Series. This new digital format will feature live panel discussions, keynote presentations, and interactive conversations across multiple days.
COVID-19 Webinar Series Session 20 – Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic and Where We Go From Here
Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders will examine the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.
During this webinar, panelists addressed the following learning goals: the short- and long-term impact of COVID-19 on mental health and well being; evidence-based interventions and promising technology to reach people where they are and improve outcomes; and sustainable solutions to address the mental health impact of COVID-19 and advance access to behavioral health services beyond the pandemic.
COVID-19 Webinar Series Session 18 – Health Inequities: Addressing the Disease Burden in Black, Indigenous, and People of Color Communities
During this webinar, speakers examined the following learning goals: the disproportionate impact of COVID-19 on Black, Indigenous, and People of Color communities in the U.S.; the drivers of these disparities; and short- and long-term policy options to advance equity and improve COVID-19 outcomes.
This webinar will explain the role of Medicaid in the COVID-19 pandemic. Panelists will discuss financing challenges of the Medicaid program—the nation’s health care safety net—as more people become eligible for Medicaid coverage and demand for health services shifts.
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
COVID-19 Webinar Series Session 14 – Lessons from Home and Abroad: Implementing a Contact Tracing Strategy
During this webinar, panelists discussed case studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
During this webinar, panelists discussed policy options to support high quality care for nursing home residents during the COVID-19 pandemic.
COVID-19 Webinar Series Session 12 – From Data to Decisions: Mobilizing a Surveillance Infrastructure
During this webinar, panelists will explore options policymakers can pursue to strengthen our surveillance infrastructure as we move from mitigation to containment of the COVID-19 pandemic.
In this webinar, panelists will discuss the unique challenges that face rural health systems and the strategies they are employing during the emergency response. They will also highlight current or future legislative and administrative policy solutions.
During this webinar, experts discussed steps necessary to bring vaccines from the lab to the front lines.
During this webinar, panelists discussed the consequences of social isolation, as well as potential interventions that government leaders, providers, and communities can implement.
During this pre-recorded interview, we spoke with Dr. Richard A. Stone, the VHA’s Executive in Charge. He explained the coronavirus response efforts underway at the Department of Veterans Affairs to meet the needs of veterans and fulfill the department’s “Fourth Mission” to support other health systems responding to this crisis.
COVID-19 Webinar Series Session 8 – Advancing Prevention and Treatment: A Conversation with Dr. Mark McClellan
During this webinar, Dr. Mark McClellan, former FDA Commissioner and current director of the Duke-Margolis Center for Health Policy, offered strategies to expedite the development and evaluation of medical products to track, treat, and prevent the novel coronavirus.
The rapid spread of the novel coronavirus has led to a growing number of COVID-19 hospitalizations and concerns about health system capacity. Models and projections can be useful tools to help policymakers at the state and local levels make evidence-based decisions to slow the spread of the virus and bolster health system capacity. During this webinar, panelists highlighted the role of modeling in helping states prepare and respond to COVID-19.
During this pre-recorded interview, we spoke with Dr. Rebecca Katz, who explored how decision-makers can use these tools to weigh policy tradeoffs. She discussed the range of existing models, as well as the key inputs and assumptions that drive projections.
This week, Congress is set to pass the third major legislative package in response to the COVID-19 outbreak. This webinar offered a high-level analysis of the policies that Congress and the administration have pursued to date and what we can expect in the coming months.
During this webinar, Michael J. Alkire, the president of Premier—the largest global health care supply chain in the U.S.—provided a frontline perspective on the state of the medical supply chain.
This webinar explored challenges to protect health care workers at the frontline of the COVID-19 response. Our panelists highlighted innovative approaches to bolster health system capacity and protect providers, such as increasing the availability of telemedicine.
COVID-19 Webinar Series Session 3 – Leading through Crisis: Perspectives from Gov. Michael O. Leavitt
Michael O. Leavitt, former Governor of Utah and former Secretary of the United States Department of Health and Human Services, explored the levers available to policymakers at the local, state, and federal levels as they respond to the novel coronavirus.
This webinar provided insight into the experience of health officials at the front lines of the COVID-19 response and explored steps policymakers can take to support these entities.
During this webinar, Dr. Kathleen Winter, an assistant professor at the University of Kentucky College of Public Health, explained the epidemiology of the novel coronavirus and discussed evidence-based practices to slow the transmission.
During this on-the-record briefing for reporters, Admiral Brett P. Giroir, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided opening remarks and responded to questions from reporters.
This webinar covered the ruling and what to expect in the coming weeks and months from the courts, Congress, and the health care market.
During this on-the-record briefing for reporters, Dr. Mona Siddiqui, Chief Data Officer in the Office of the Chief Technology Officer at the U.S. Department of Health and Human Services, will provide opening remarks and respond to questions from reporters.
During this briefing, panelists discussed factors policymakers must consider in order to support access to safe, effective, and affordable cell and gene therapies.
This webinar will orient audience members to the current landscape of the long-term care delivery system, its funding mechanisms, and the state and federal legislation that model this system. Panelists will discuss and offer insights about potential solutions to create an accessible and financially sustainable long-term care system.
During this on-the-record briefing for reporters, Joe Grogan, Assistant to the President and Director of the Domestic Policy Council provided opening remarks and responded to questions from reporters. The question and answer period was moderated by William Pierce, Senior Director, APCO Worldwide.